ESCMID

ESCMID

escmid.bsky.social

Championing medical progress in infection for a healthier tomorrow. ESCMID is committed to advancing the fields of clinical microbiology and infectious diseases.

👤 Joined on 04 September 2024

5487

Followers

176

Following

1244

Total Posts

📜 Kullanıcı Geçmişi

  • 04 Eyl 2024, 11:29
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @escmid.bsky.social

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

Original article evaluating whether early antifungal prophylaxis reduces the incidence of influenza-associated pulmonary aspergillosis (IAPA) in critically ill adults with influenza: www.clinicalmicrobiologyandinfection.org/article/S119... #IDSky #clinmicro #MedSky

Show Post

📣 In the October 2026 issue: The @escmid.bsky.social framework for reaching consensus in clinical guidelines www.clinicalmicrobiologyandinfection.org/article/S119... #IDSky #MicroSky

Show Post

🎙️ Just published 'Does oseltamivir harm critically ill patients? The REMAP-CAP results' Hosted by Erin McCreary, PharmD & Josh Davis with invited guests Steve Webb & Steven Tong 🌟 Listen on #Communicable https://ow.ly/pJAO50ZOfK8 or on #Breakpoints https://ow.ly/p8Ti50ZOfK9 #IDSky #ViroSky #flu

Show Post

📣 New #Communicable / #Breakpoints drops Mon 21 Sep! Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs. #IDSky #ViroSky #flu

Show Post

In honor of #PeerReviewWeek we would like to thank our peer reviewers for their important and insightful contributions to CMI. We deeply value the time, effort and expertise that goes into writing each peer-review.

Show Post

Select language

Install App

Install App